Click on an episode below to hear first-hand how industry experts have rewritten the rules to overcome significant biopharma analytical challenges.
Click on an episode below to hear first-hand how industry experts have rewritten the rules to overcome significant biopharma analytical challenges.
with Mike McKinnon, Senior Scientist II, Novartis
In this episode, we discuss the challenges of new modalities and how new analytical methods can address the evolving challenges in biotherapeutic characterization.
with Jérémie Parot, PhD, Research Scientist, SINTEF
In this episode, we explore the difficulties faced when characterizing mRNA and the opportunities that mRNA research brings to medicine.
with Adam Crowe, PhD, Sr. Manager, Analytical Development, Precision NanoSystems ULC (part of Cytiva)
In this episode, we take a deep dive into the importance of ionizable lipids in lipid nanoparticles (LNPs) and why new analytical workflows are needed for this expanding field.
with Kristen Nields, PhD, Senior Scientist, Janssen
In this episode, we explore the challenges in charge variant analysis and how to address the bottlenecks with new workflow approaches.
with Tyler Heibeck, PhD, Principal Scientist, Sutro Biopharma
In this episode, we talk about the surprises and challenges encountered in drug development and how new analytical approaches may help find the answer.
with Jill Bradley-Graham, PhD, Senior Scientist, Gene and Cell Therapy BioAnalytics, Sanofi
In this episode, we discuss why viral vector characterization is particularly challenging and how collaboration is key for newly emerging fields.
with Shane Karnik, Senior Laboratory Director, Aliri Bioanalysis
In this episode, we discuss what bioanalysis is and how bioanalysis of oligonucleotides differs from that of other modalities.
with Thomas Kofoed, PhD, Co-founder and CEO, Alphalyse
In this episode, we chat about host cell proteins (HCPs), the importance of their analysis in cell and gene therapy products and the challenges of this field.
with Hugo Gagnon, PhD, Chief Scientific Officer, Allumiqs
In this episode, we take a deep dive into what gene editing is and uncover why establishing analytics for gene editing is such a complex task.
Reclaim time for innovation by identifying and advancing drug candidates more confidently with analytical strategies that support your team across modalities, from discovery to commercialization.
A high-resolution mass spectrometry solution that combines powerful MS/MS sensitivity, fragmentation technology and a step-change in data independent acquisition.
Be empowered with highly accurate and informative workflows for fully characterizing protein therapeutics and viral vector proteins.
Release and label glycoprotein N-linked glycans for high-resolution capillary electrophoresis using laser-induced fluorescence (LIF) detection and an HR-NCHO separation matrix.